What is the problem you're trying to solve?
We are seeking to create novel antibody-based therapeutics for oncology. With our SnAP (Site-specific novel Antibody Platform) technology, we believe we have the potential to improve upon current antibody-based products to yield an array of potent, stable and cost-effective new products from a single antibody.
How is what you're doing different than other attempts to solve this problem?
Our technology harnesses a unique, proprietary site in the Fab of an antibody.SnAP provides a LEGO-like ability to easily, consistently and cheaply ‘snap’ a variety of payloads onto an antibody – and the ability to do so ex- or in-vivo.
Why are you passionate about what you're working on?
Everyone on our team has lost a close family member to cancer.We are devoted and committed to making better and safer therapeutics so as to improve the longevity and quality of living of future cancer patients and their families.
What achievement are you most proud of?
The building of this amazing team!In an impressive short-period of time and on a shoe-string budget, we validated the technology and created not only a compelling early pipeline, but also new technologies/inventions of our own.